个人中心 - 老虎社区

ghshs

IP属地：湖北

帖子 · 6帖子 · 6
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- ghshsghshs
  ·2022-09-09
  还有查尔斯三世呢！
  非常抱歉，此主贴已删除
  2,146 评论
  点赞
  分享
  举报
- ghshsghshs
  ·2022-03-29
  无非是打着研发的幌子骗取财税补贴罢了！
  非常抱歉，此主贴已删除
  2,440 评论
  2
  分享
  举报
- ghshsghshs
  ·2021-11-04
  滴滴的调查结果什么时候出来呀！这都4个月了，该有个结果了吧！
  4,832 3
  7
  分享
  举报
- ghshsghshs
  ·2021-10-25
  那言外之意是高中阶段还可以开展校外培训？
  新东方在线：将停止经营中国内地义务教育阶段学科类校外培训服务
  10月25日，新东方在线港交所公告：根据新规定及为确保本集团及其营运完全遵守所有适用的法律和监管要求，本公司董事会已决定，本集团将停止经营中国内地义务教育阶段学科类校外培训服务，其乃提供予中国内地幼儿
  新东方在线：将停止经营中国内地义务教育阶段学科类校外培训服务
  3,197 1
  点赞
  分享
  举报
- ghshsghshs
  ·2021-09-28
  $滴滴(DIDI)$这么长时间了，该审查的应该都审查清楚了吧，可以放人了吧！老是这么压着，算怎么一回事🤔
  9,131 7
  8
  分享
  举报
- ghshsghshs
  ·2021-08-19
  有人中签吗？
  心玮医疗-B一手中签率10%，认购200手稳中一手
  8月19日，心玮医疗-B发布公告，公司发行约660.19万股股份，每股定价171港元，每手50股，预期8月20日上市。公开发售阶段心玮医疗-B获约333.14倍认购，分配至公开发售的发售股份最终数目
  心玮医疗-B一手中签率10%，认购200手稳中一手
  2,721 评论
  1
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3581413328842505","uuid":"3581413328842505","gmtCreate":1618320145260,"gmtModify":1626495019717,"name":"ghshs","pinyin":"ghshs","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/139197b84aa474e80540fc13943b059d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":87,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":34,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-1","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识体验官","description":"观看学堂课程满5节","bigImgUrl":"https://static.tigerbbs.com/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://static.tigerbbs.com/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":1,"location":"湖北","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":3,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":663986667,"gmtCreate":1662735775060,"gmtModify":1662735776435,"author":{"id":"3581413328842505","authorId":"3581413328842505","name":"ghshs","avatar":"https://static.tigerbbs.com/139197b84aa474e80540fc13943b059d","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3581413328842505","idStr":"3581413328842505"},"themes":[],"htmlText":"还有查尔斯三世呢！","listText":"还有查尔斯三世呢！","text":"还有查尔斯三世呢！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/663986667","repostId":"1180933283","repostType":4,"isVote":1,"tweetType":1,"viewCount":2146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":610342683,"gmtCreate":1648534917056,"gmtModify":1648534917056,"author":{"id":"3581413328842505","authorId":"3581413328842505","name":"ghshs","avatar":"https://static.tigerbbs.com/139197b84aa474e80540fc13943b059d","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3581413328842505","idStr":"3581413328842505"},"themes":[],"htmlText":"无非是打着研发的幌子骗取财税补贴罢了！","listText":"无非是打着研发的幌子骗取财税补贴罢了！","text":"无非是打着研发的幌子骗取财税补贴罢了！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/610342683","repostId":"1169143108","repostType":4,"isVote":1,"tweetType":1,"viewCount":2440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848261862,"gmtCreate":1636002876627,"gmtModify":1636002876627,"author":{"id":"3581413328842505","authorId":"3581413328842505","name":"ghshs","avatar":"https://static.tigerbbs.com/139197b84aa474e80540fc13943b059d","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3581413328842505","idStr":"3581413328842505"},"themes":[],"htmlText":"滴滴的调查结果什么时候出来呀！这都4个月了，该有个结果了吧！","listText":"滴滴的调查结果什么时候出来呀！这都4个月了，该有个结果了吧！","text":"滴滴的调查结果什么时候出来呀！这都4个月了，该有个结果了吧！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":1,"link":"https://laohu8.com/post/848261862","isVote":1,"tweetType":1,"viewCount":4832,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856175411,"gmtCreate":1635165583993,"gmtModify":1635165583993,"author":{"id":"3581413328842505","authorId":"3581413328842505","name":"ghshs","avatar":"https://static.tigerbbs.com/139197b84aa474e80540fc13943b059d","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3581413328842505","idStr":"3581413328842505"},"themes":[],"htmlText":"那言外之意是高中阶段还可以开展校外培训？","listText":"那言外之意是高中阶段还可以开展校外培训？","text":"那言外之意是高中阶段还可以开展校外培训？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/856175411","repostId":"1148174449","repostType":4,"repost":{"id":"1148174449","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635164850,"share":"https://www.laohunote.com/m/news/1148174449?lang=&edition=full","pubTime":"2021-10-25 20:27","market":"us","language":"zh","title":"新东方在线：将停止经营中国内地义务教育阶段学科类校外培训服务","url":"https://stock-news.laohu8.com/highlight/detail?id=1148174449","media":"老虎资讯综合","summary":"10月25日，新东方在线港交所公告：根据新规定及为确保本集团及其营运完全遵守所有适用的法律和监管要求，本公司董事会已决定，本集团将停止经营中国内地义务教育阶段学科类校外培训服务，其乃提供予中国内地幼儿","content":"<p>10月25日，<a href=\"https://laohu8.com/S/01797\">新东方在线</a>港交所公告：根据新规定及为确保本集团及其营运完全遵守所有适用的法律和监管要求，本公司董事会已决定，本集团将停止经营中国内地义务教育阶段学科类校外培训服务，其乃提供予中国内地幼儿园至九年级（K-9或义务教育）的学生。终止预计于2021年11月末之前生效。</p>\n<p>董事会预计，终止将对本集团截至2022年5月31日止财政年度及后续期间的总营收产生重大不利影响；然而，鉴于截至2021年5月31日止两个财政年度K-12业务分部产生亏损，董事会预计本集团的溢利将受到积极影响。</p>\n<p><img src=\"https://static.tigerbbs.com/0209e911d2aa89ed37f6f355647cabd4\" tg-width=\"841\" tg-height=\"738\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>新东方在线：将停止经营中国内地义务教育阶段学科类校外培训服务</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n新东方在线：将停止经营中国内地义务教育阶段学科类校外培训服务\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-10-25 20:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>10月25日，<a href=\"https://laohu8.com/S/01797\">新东方在线</a>港交所公告：根据新规定及为确保本集团及其营运完全遵守所有适用的法律和监管要求，本公司董事会已决定，本集团将停止经营中国内地义务教育阶段学科类校外培训服务，其乃提供予中国内地幼儿园至九年级（K-9或义务教育）的学生。终止预计于2021年11月末之前生效。</p>\n<p>董事会预计，终止将对本集团截至2022年5月31日止财政年度及后续期间的总营收产生重大不利影响；然而，鉴于截至2021年5月31日止两个财政年度K-12业务分部产生亏损，董事会预计本集团的溢利将受到积极影响。</p>\n<p><img src=\"https://static.tigerbbs.com/0209e911d2aa89ed37f6f355647cabd4\" tg-width=\"841\" tg-height=\"738\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/0449833ee4bd3e2db783cdd1924d9ddc","relate_stocks":{"09901":"新东方-S","EDU":"新东方","01797":"东方甄选"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148174449","content_text":"10月25日，新东方在线港交所公告：根据新规定及为确保本集团及其营运完全遵守所有适用的法律和监管要求，本公司董事会已决定，本集团将停止经营中国内地义务教育阶段学科类校外培训服务，其乃提供予中国内地幼儿园至九年级（K-9或义务教育）的学生。终止预计于2021年11月末之前生效。\n董事会预计，终止将对本集团截至2022年5月31日止财政年度及后续期间的总营收产生重大不利影响；然而，鉴于截至2021年5月31日止两个财政年度K-12业务分部产生亏损，董事会预计本集团的溢利将受到积极影响。","news_type":1},"isVote":1,"tweetType":1,"viewCount":3197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862948944,"gmtCreate":1632833983731,"gmtModify":1632833983731,"author":{"id":"3581413328842505","authorId":"3581413328842505","name":"ghshs","avatar":"https://static.tigerbbs.com/139197b84aa474e80540fc13943b059d","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3581413328842505","idStr":"3581413328842505"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DIDI\">$滴滴(DIDI)$</a>这么长时间了，该审查的应该都审查清楚了吧，可以放人了吧！老是这么压着，算怎么一回事🤔","listText":"<a href=\"https://laohu8.com/S/DIDI\">$滴滴(DIDI)$</a>这么长时间了，该审查的应该都审查清楚了吧，可以放人了吧！老是这么压着，算怎么一回事🤔","text":"$滴滴(DIDI)$这么长时间了，该审查的应该都审查清楚了吧，可以放人了吧！老是这么压着，算怎么一回事🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/862948944","isVote":1,"tweetType":1,"viewCount":9131,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3556090761819571","authorId":"3556090761819571","name":"jrlx","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3556090761819571","idStr":"3556090761819571"},"content":"阿里反垄断弄了4个多月，这个七部门联合审查时间短不了","text":"阿里反垄断弄了4个多月，这个七部门联合审查时间短不了","html":"阿里反垄断弄了4个多月，这个七部门联合审查时间短不了"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":831775314,"gmtCreate":1629354815238,"gmtModify":1629354815238,"author":{"id":"3581413328842505","authorId":"3581413328842505","name":"ghshs","avatar":"https://static.tigerbbs.com/139197b84aa474e80540fc13943b059d","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3581413328842505","idStr":"3581413328842505"},"themes":[],"htmlText":"有人中签吗？","listText":"有人中签吗？","text":"有人中签吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/831775314","repostId":"1186507371","repostType":2,"repost":{"id":"1186507371","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629337994,"share":"https://www.laohunote.com/m/news/1186507371?lang=&edition=full","pubTime":"2021-08-19 09:53","market":"hk","language":"zh","title":"心玮医疗-B一手中签率10%，认购200手稳中一手","url":"https://stock-news.laohu8.com/highlight/detail?id=1186507371","media":"老虎资讯综合","summary":"8月19日，心玮医疗-B发布公告，公司发行约660.19万股股份，每股定价171港元，每手50股，预期8月20日上市。\n公开发售阶段心玮医疗-B获约333.14倍认购，分配至公开发售的发售股份最终数目","content":"<p>8月19日，<a href=\"https://laohu8.com/S/06609\">心玮医疗-B</a>发布公告，公司发行约660.19万股股份，每股定价171港元，每手50股，预期8月20日上市。</p>\n<p>公开发售阶段心玮医疗-B获约333.14倍认购，分配至公开发售的发售股份最终数目为330.1万股，占发售股份总数的50%（任何超额配股权获行使前）。合共接获235040份有效申请，一手中签率10%，认购200手稳中一手。</p>\n<p>此外，国际发售获大幅超额认购，发售股份最终数目为330.085万股，相当于发售股份总数的50%（任何超额配股权获行使前）。老虎资讯整理相关数据如下表：</p>\n<p><b>分配结果：</b></p>\n<p><img src=\"https://static.tigerbbs.com/aad5f38d34206bbf5997df41e7c9addb\" tg-width=\"694\" tg-height=\"582\" referrerpolicy=\"no-referrer\">甲组每手50股，一手中签率10%，认购200手稳中一手。</p>\n<p>乙组门槛为3万股（600手），获配500股（10手）。<img src=\"https://static.tigerbbs.com/a7f3be534deef2bd4be2d0bd65ac98d3\" tg-width=\"586\" tg-height=\"625\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/24d8aebb770aaafa24861f765ba64b9e\" tg-width=\"548\" tg-height=\"241\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f89e31ecb8941d10d217fbe7c93a3a2b\" tg-width=\"581\" tg-height=\"328\" referrerpolicy=\"no-referrer\">筹资用途方面，公司拟将全球发售净筹约10.15亿港元用作以下用途：45.3%元预期将分配至公司的核心产品；39.9%分配至公司管线内的其他在研产品；4.8%用于为透过内部研究提升研发能力及持续扩充产品组合提供资金；10.0%将用作营运资金及一般企业用途。</p>\n<p>基石投资者方面，公司的基石投资者已认购合共300.06万股股份，合共相当于全球发售完成后公司已发行股本的约7.73%，及约全球发售的发售股份数目的45.45%，认购总额约6600万美元。</p>\n<p><img src=\"https://static.tigerbbs.com/c2551db1817d5729212be2f0fae5f40e\" tg-width=\"858\" tg-height=\"771\" referrerpolicy=\"no-referrer\">心玮医疗是一家创新型神经介入医疗器械公司，凭借商业化产品及在研产品的广泛产品组合在中国神经介入市场占据领导地位，公司产品组合包括神经介入及心脏医疗器械。</p>\n<p>目前心玮医疗在中国拥有四款商业化产品和19款获批产品及在研产品，其两款核心产品分别是Captor™取栓器械及左心耳封堵器。Captor是为急性缺血性脑卒中而设，且已在中国商业化，而左心耳(LAA)封堵器是为心房颤动而设，正待NMPA注册审查。</p>\n<p>财务数据方面，公司于2020年一季度开始商业化SupSelek™微导管及ExtraFlex™远端通路导管方开始产生收益。于往绩记录期间，公司均录得经营亏损。于2019年、2020年及2021年前三个月，公司录得亏损人民币7549.8万元、2.16亿元及4129.7万元。<img src=\"https://static.tigerbbs.com/ecdb76f206c27f2eeaa25878b1976468\" tg-width=\"784\" tg-height=\"653\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>心玮医疗-B一手中签率10%，认购200手稳中一手</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n心玮医疗-B一手中签率10%，认购200手稳中一手\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-08-19 09:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>8月19日，<a href=\"https://laohu8.com/S/06609\">心玮医疗-B</a>发布公告，公司发行约660.19万股股份，每股定价171港元，每手50股，预期8月20日上市。</p>\n<p>公开发售阶段心玮医疗-B获约333.14倍认购，分配至公开发售的发售股份最终数目为330.1万股，占发售股份总数的50%（任何超额配股权获行使前）。合共接获235040份有效申请，一手中签率10%，认购200手稳中一手。</p>\n<p>此外，国际发售获大幅超额认购，发售股份最终数目为330.085万股，相当于发售股份总数的50%（任何超额配股权获行使前）。老虎资讯整理相关数据如下表：</p>\n<p><b>分配结果：</b></p>\n<p><img src=\"https://static.tigerbbs.com/aad5f38d34206bbf5997df41e7c9addb\" tg-width=\"694\" tg-height=\"582\" referrerpolicy=\"no-referrer\">甲组每手50股，一手中签率10%，认购200手稳中一手。</p>\n<p>乙组门槛为3万股（600手），获配500股（10手）。<img src=\"https://static.tigerbbs.com/a7f3be534deef2bd4be2d0bd65ac98d3\" tg-width=\"586\" tg-height=\"625\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/24d8aebb770aaafa24861f765ba64b9e\" tg-width=\"548\" tg-height=\"241\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f89e31ecb8941d10d217fbe7c93a3a2b\" tg-width=\"581\" tg-height=\"328\" referrerpolicy=\"no-referrer\">筹资用途方面，公司拟将全球发售净筹约10.15亿港元用作以下用途：45.3%元预期将分配至公司的核心产品；39.9%分配至公司管线内的其他在研产品；4.8%用于为透过内部研究提升研发能力及持续扩充产品组合提供资金；10.0%将用作营运资金及一般企业用途。</p>\n<p>基石投资者方面，公司的基石投资者已认购合共300.06万股股份，合共相当于全球发售完成后公司已发行股本的约7.73%，及约全球发售的发售股份数目的45.45%，认购总额约6600万美元。</p>\n<p><img src=\"https://static.tigerbbs.com/c2551db1817d5729212be2f0fae5f40e\" tg-width=\"858\" tg-height=\"771\" referrerpolicy=\"no-referrer\">心玮医疗是一家创新型神经介入医疗器械公司，凭借商业化产品及在研产品的广泛产品组合在中国神经介入市场占据领导地位，公司产品组合包括神经介入及心脏医疗器械。</p>\n<p>目前心玮医疗在中国拥有四款商业化产品和19款获批产品及在研产品，其两款核心产品分别是Captor™取栓器械及左心耳封堵器。Captor是为急性缺血性脑卒中而设，且已在中国商业化，而左心耳(LAA)封堵器是为心房颤动而设，正待NMPA注册审查。</p>\n<p>财务数据方面，公司于2020年一季度开始商业化SupSelek™微导管及ExtraFlex™远端通路导管方开始产生收益。于往绩记录期间，公司均录得经营亏损。于2019年、2020年及2021年前三个月，公司录得亏损人民币7549.8万元、2.16亿元及4129.7万元。<img src=\"https://static.tigerbbs.com/ecdb76f206c27f2eeaa25878b1976468\" tg-width=\"784\" tg-height=\"653\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/4bf777735f6221ee91844b452a15e3fd","relate_stocks":{"06609":"心玮医疗-B"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186507371","content_text":"8月19日，心玮医疗-B发布公告，公司发行约660.19万股股份，每股定价171港元，每手50股，预期8月20日上市。\n公开发售阶段心玮医疗-B获约333.14倍认购，分配至公开发售的发售股份最终数目为330.1万股，占发售股份总数的50%（任何超额配股权获行使前）。合共接获235040份有效申请，一手中签率10%，认购200手稳中一手。\n此外，国际发售获大幅超额认购，发售股份最终数目为330.085万股，相当于发售股份总数的50%（任何超额配股权获行使前）。老虎资讯整理相关数据如下表：\n分配结果：\n甲组每手50股，一手中签率10%，认购200手稳中一手。\n乙组门槛为3万股（600手），获配500股（10手）。筹资用途方面，公司拟将全球发售净筹约10.15亿港元用作以下用途：45.3%元预期将分配至公司的核心产品；39.9%分配至公司管线内的其他在研产品；4.8%用于为透过内部研究提升研发能力及持续扩充产品组合提供资金；10.0%将用作营运资金及一般企业用途。\n基石投资者方面，公司的基石投资者已认购合共300.06万股股份，合共相当于全球发售完成后公司已发行股本的约7.73%，及约全球发售的发售股份数目的45.45%，认购总额约6600万美元。\n心玮医疗是一家创新型神经介入医疗器械公司，凭借商业化产品及在研产品的广泛产品组合在中国神经介入市场占据领导地位，公司产品组合包括神经介入及心脏医疗器械。\n目前心玮医疗在中国拥有四款商业化产品和19款获批产品及在研产品，其两款核心产品分别是Captor™取栓器械及左心耳封堵器。Captor是为急性缺血性脑卒中而设，且已在中国商业化，而左心耳(LAA)封堵器是为心房颤动而设，正待NMPA注册审查。\n财务数据方面，公司于2020年一季度开始商业化SupSelek™微导管及ExtraFlex™远端通路导管方开始产生收益。于往绩记录期间，公司均录得经营亏损。于2019年、2020年及2021年前三个月，公司录得亏损人民币7549.8万元、2.16亿元及4129.7万元。","news_type":1},"isVote":1,"tweetType":1,"viewCount":2721,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}